First Time Loading...
S

Santhera Pharmaceuticals Holding AG
SIX:SANN

Watchlist Manager
Santhera Pharmaceuticals Holding AG
SIX:SANN
Watchlist
Price: 9.37 CHF 1.19%
Updated: May 3, 2024

Income Statement

Earnings Waterfall
Santhera Pharmaceuticals Holding AG

Revenue
5.2m CHF
Cost of Revenue
-3.6m CHF
Gross Profit
1.5m CHF
Operating Expenses
-48.3m CHF
Operating Income
-46.7m CHF
Other Expenses
-17.9m CHF
Net Income
-64.7m CHF

Income Statement
Santhera Pharmaceuticals Holding AG

Rotate your device to view
Income Statement
Currency: CHF
Sep-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023
Revenue
Revenue
30
N/A
32
+5%
42
+31%
75
+81%
65
-14%
15
-77%
12
-22%
(2)
N/A
0
N/A
7
+4 485%
5
-31%
Gross Profit
Cost of Revenue
(5)
(5)
(6)
(5)
(5)
(10)
(10)
(4)
(4)
(4)
(4)
Gross Profit
26
N/A
27
+6%
36
+32%
70
+97%
60
-14%
5
-92%
1
-70%
(5)
N/A
(3)
+36%
4
N/A
2
-61%
Operating Income
Operating Expenses
(79)
(78)
(94)
(80)
(74)
(58)
(48)
(52)
(60)
(56)
(48)
Selling, General & Administrative
(43)
(40)
(47)
(39)
(34)
(24)
(18)
(22)
(27)
(25)
(25)
Research & Development
(35)
(38)
(47)
(41)
(40)
(34)
(30)
(30)
(33)
(31)
(23)
Other Operating Expenses
(0)
0
0
0
0
0
0
0
0
0
0
Operating Income
(53)
N/A
(51)
+4%
(58)
-14%
(10)
+82%
(14)
-33%
(53)
-282%
(47)
+12%
(57)
-22%
(63)
-11%
(52)
+18%
(47)
+10%
Pre-Tax Income
Interest Income Expense
(3)
(2)
(7)
(8)
(9)
(6)
(12)
(8)
(1)
(21)
(20)
Total Other Income
0
(0)
0
0
(1)
(8)
3
10
(0)
2
2
Pre-Tax Income
(57)
N/A
(54)
+5%
(65)
-21%
(18)
+72%
(23)
-27%
(67)
-189%
(56)
+17%
(55)
+2%
(64)
-17%
(71)
-10%
(65)
+8%
Net Income
Tax Provision
(2)
(0)
(1)
(1)
(1)
(0)
(0)
(1)
(1)
(0)
0
Income from Continuing Operations
(58)
(54)
(66)
(19)
(24)
(68)
(56)
(56)
(65)
(71)
(65)
Net Income (Common)
(58)
N/A
(54)
+7%
(66)
-22%
(19)
+71%
(24)
-26%
(68)
-183%
(56)
+17%
(56)
+1%
(65)
-17%
(71)
-10%
(65)
+9%
EPS (Diluted)
-8.96
N/A
-7.86
+12%
-6.08
+23%
-1.73
+72%
-2.08
-20%
-50.81
-2 343%
-2.53
+95%
-16.27
-543%
-11.42
+30%
-11.67
-2%
-57.96
-397%

See Also

Discover More